FSNUY
Fresenius SE & Co. KGaAPrice & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FSNUY
this stock
Fresenius SE & Co. KGaA
|
$27.26B | -15.6% | — | — | 0.0% |
|
HCA
HCA Healthcare, Inc.
|
$91.07B | -11.9% | +7.1% | 14.1 | 2.4% |
|
THC
Tenet Healthcare Corp
|
$17.55B | +2.5% | -2.3% | 10.6 | 4.7% |
|
DVA
Davita Inc.
|
$15.08B | +106.8% | +6.5% | 21.9 | 7.2% |
|
FMS
Fresenius Medical Care AG
|
$12.64B | -1.2% | — | — | 1.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FSNUY | +5.5% | +15.1% | -16.6% | +5.9% | -15.6% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +4.1% | +16.4% | -24.6% | +6.1% | -24.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.